It is generally accepted that patients with non-subarachnoid hemorrhagic ICH have a lower incidence of developing chronic hydrocephalus than patients with aneurysmal subarachnoid hemorrhage [16, 17]. For patients with aneurysmal subarachnoid hemorrhage, the disturbance of normal CSF drainage to the venous sinuses resulted from subarachnoid blood clots or an inflammatory environment causing excess accumulation of CSF in the ventricles. However, a more intricate interaction of factors, such as hematoma-related CSF flow obstruction, deteriorative ventricular compliance, impaired CSF reabsorption, and post-hemorrhagic inflammation, may be associated with shunt dependency in patients with non-subarachnoid hemorrhagic ICH.
Several predictors of permanent hydrocephalus have been reported, including poor GCS score at admission [18], thalamic ICH location [10], elevated ICP level [10, 12, 19–21], hypertension, and slow CSF circulation [22]. Furthermore, huge variability concerning the incidence of shunt-dependent hydrocephalus in patients with spontaneous IVH has been reported [23]. The CLEAR III trial in 2017 showed an incidence of long-term shunt placement of 18% [24], whereas Gluski et al. [25] reported an incidence of 1.6% in their study. Zacharia et al. [10] and Miller et al. [12] reported 20% and 28.3% shunt dependency rates, respectively. A similar result showing that an elevated ICP level and the presence of IVH on arrival are associated with higher rates of shunt-dependent hydrocephalus was observed in these studies. However, Gluski et al. [25] reported that hemorrhage location surprisingly did not predict shunt dependency but did correlate with functional outcomes.
In this study, 46 patients (25.7%) required permanent CSF diversion resulting from chronic hydrocephalus status after a hemorrhagic event. GCS at arrival, ICH location, mGraeb scores, and bicaudate index were associated with permanent shunt dependency in patients with IVH. In the multivariable-adjusted model, GCS at arrival, thalamic ICH, mGraeb scores, and bicaudate index were significantly associated with shunt dependency after EVD placement. Previous studies have shown an association between infratentorial ICH and poor outcomes. However, strong evidence regarding the relationship between pons/cerebellar ICH and shunt dependency is still needed [26, 27]. In this study, although pons and cerebellar ICH showed a higher OR than thalamic ICH (OR 4.52; 95%CI 0.95–21.64; p = 0.059 for cerebellar ICH and OR 5.38; 95%CI 0.85–34.02; p = 0.074 for pons ICH), these two factors did not reach statistical significance. Kuo et al proposed that a hematoma in the third and fourth ventricles showed a more significant association with shunt dependency than that in the lateral ventricles [14]. Further studies and clinical evidence are needed to determine whether pons and cerebellar ICH-related third and fourth ventricle obstruction will result in a permanent shunt requirement in patients with ICH.
The bicaudate index is one of the commonly used tools to define hydrocephalus in clinical practice. Previous studies have reported a positive correlation between age and the bicaudate index [28–31]. Dhok et al showed that the difference in the mean values of both sexes was statistically significant. In this study, a threshold of 0.16 was found via the ROC analysis to evaluate the association between the bicaudate index and shunt dependency. A multivariable logistic regression model was adjusted for age and sex. The results showed that a value of the bicaudate index higher than 0.16 was a significant predictor of permanent CSF diversion.
A subgroup statistical analysis was performed regarding intraventricular fibrinolysis (IVF) use in patients with IVH. The results showed that neither urokinase administration (p = 0.533) nor urokinase dosage (p = 0.117) showed significant relevance in shunt dependency prevention. Regarding IVF use, previous reviews have been cautiously optimistic [32–34], with a lower risk of mortality and ventriculitis. Similar positive findings with lower mortality were proposed by van Solinge et al. [35]. However, the same study also found no significant difference in shunt dependency but an increase in symptomatic hemorrhages in patients receiving IVF. Covrig et al. [36] conducted a retrospective study including 102 patients with IVH or ICH over 7 years to compare the effect of urokinase versus alteplase (recombinant tissue plasminogen activator (rt-PA)). The results showed 12.2% shunt dependency in the urokinase group and 15.0% in the rt-PA group, with no statistically significant difference between both groups.
This study has some limitations. It was a retrospective analysis with a relatively small sample size due to the strict inclusion criteria. Additionally, no unified EVD challenge protocol or definition of shunt-dependent hydrocephalus was reported. Consequently, the need for a permanent CSF shunt was entirely decided by surgeons according to clinical symptoms, image findings, and personal experience. These subjective factors further influence the shunt placement interval and essentiality and make it difficult to generalize the results.